Strong Competition In Europe Expected For Irbesartan – YAHOO!

recently published an article based on its proprietary Pipeline Patent Intelligence that analyses opportunities in launching generic versions of Sanofi/Bristol Myers Squibb’s antihypertensive drug Irbesartan (Aprovel®/CoAprovel®, Avapro®/Avalide …

Leave a Reply

Your email address will not be published. Required fields are marked *

*